Discuss This Drug

plasminogen

CHEBI:CHEBI_753415

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
plasminogen
brand_name
Ryplazim
brand_name_base
Ryplazim
listing_expiration_date
20251231
marketing_start_date
20210604
package_marketing_start_date
20210604
route
INTRAVENOUS
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
marketing_category
BLA
product_type
PLASMA DERIVATIVE
product_ndc
70573-099
application_number
BLA125659
labeler_name
Kedrion Biopharma, Inc.
spl_id
80993614-6c8a-4968-82e6-b870c9eb4db3
active_ingredient_name
PLASMINOGEN
active_ingredient_strength
68.8 mg/1
package_ndc
70573-099-02
package_description
1 VIAL, GLASS in 1 CARTON (70573-099-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (70573-099-01)
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class